4 Grants
2021
Use of Human Stem Cell-derived RGCs to Study the Mechanism of Optineurin-associated Glaucoma
Das, Arupratan
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 5R00EY028223-04), $241,528USD, 2019-11-01 -- 2023-01-31
2020
Use of Human Stem Cell-derived RGCs to Study the Mechanism of Optineurin-associated Glaucoma
Das, Arupratan
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 4R00EY028223-03), $249,000USD, 2019-11-01 -- 2023-01-31
2018
Use of Human Stem Cell-derived RGCs to Study the Mechanism of Optineurin-associated Glaucoma
Das, Arupratan
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 5K99EY028223-02), $96,781USD, 09/01/2017 -- 08/31/2019
2017
Use of Human Stem Cell-derived RGCs to Study the Mechanism of Optineurin-associated Glaucoma
Das, Arupratan
National Institutes of Health (NIH), National Eye Institute (NEI) (ID: 1K99EY028223-01), $96,870USD, 09/01/2017 -- 08/31/2019